While analyzing the customer reviews of PrimeBiome, we primarily focused on whether customers have any major complaints ...

Randomised trial, 20-week treatment protocol plus 6-month follow up ...

Within R&D, Novo Nordisk completed the REDEFINE 2 trial, where CagriSema demonstrated superior weight loss of 15.7% in adults with obesity or overweight and type 2 diabetes. Novo Nordisk still expects ...

Dr. Falk Pharma, a research-based pharmaceutical company specializing in digestive and metabolic medicine, today announced positive results from its pivotal, phase 3 trial (NUC-5) on norucholic acid ...

Improved disease staging tool for hepatic encephalopathy, approved for use by FDA in phase 3 trials of IV ammonia scavenger (YAQ006) Dose-response data of oral ammonia scavenger (YAQ007) for ...

“These data show that the long-term efficacy, safety, and convenience profile of ALXN1840 are very encouraging and that ALXN1840 has the potential to provide a meaningful benefit to Wilson disease ...

Iantrek, Inc., a leader in bio-interventional ophthalmic surgery (BIOS), today announced it has surpassed 2,000 AlloFlo™ Uveo ...

The "Miracle in the Making" program is a testament to Faithful Fertility Collective's dedication to fostering hope and ...

In an industry filled with exaggerated claims and underwhelming results, Alpha Bites Gummies stands out for its transparency ...

Secondly, checking reported side effects (or the lack thereof) provides insight into safety and tolerance. ProstaVive is ...

The webcast of the fireside chats will be accessible in the investor section of 89bio’s website. A replay of the webcasts will be available for approximately 30 days following each conference.

Maxim Group LLC acted as sole book-running manager for the offering.